Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

The Effect of a Walking Assist Robot on Gait Function and Brain Activity in Stroke Patients and Elderly Adults

Not Applicable

Completed

Conditions: Healthy
Stroke

Interventions: Procedure: Gait, sit-to-stand movement, stair climbing and treadmill gait
Procedure: Sit-to-stand movement and treadmill gait
Device: gait enhancing mechatronic system (GEMS)
Device: treadmill

First Posted Date: 2017-02-09

Last Posted Date: 2019-04-29

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 40

Registration Number: NCT03048968

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Assessment of Kidney Function for Drug Dosage Adjustments in Critically Ill Patients

Not Applicable

Conditions: ICU Patients

Interventions: Diagnostic Test: kidney function assessment by creatinine based eGFR
Diagnostic Test: kidney function assessment by 4 hour creatinine clearance

First Posted Date: 2017-02-07

Last Posted Date: 2017-02-08

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 172

Registration Number: NCT03045692

Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR

Active, not recruiting

Conditions: Ischemic Heart Disease

Interventions: Device: Comprehensive physiologic evaluation
Device: Intravascular imaging devices

First Posted Date: 2017-01-25

Last Posted Date: 2025-05-15

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 1400

Registration Number: NCT03030495

Locations: 🇰🇷
Inje University Ilsan Paik Hospital, Goyang-si, Korea, Republic of
🇰🇷
Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of
🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

and more 1 locations

Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations

Phase 2

Completed

Conditions: Small Cell Lung Cancer

Interventions: Drug: Olaparib

First Posted Date: 2017-01-04

Last Posted Date: 2021-02-18

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 15

Registration Number: NCT03009682

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2)

Not Applicable

Completed

Conditions: Alopecia
Chemotherapy Effects

Interventions: Other: CG428

First Posted Date: 2016-12-08

Last Posted Date: 2018-09-04

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 19

Registration Number: NCT02986412

Locations: 🇰🇷
Danbee Kang, Seoul, Korea, Republic of

Research on Quantification of VR(Virtual Reality) Related Stress and Relaxation

Not Applicable

Conditions: Stress, Psychological
Motion Sickness
Visual Fatigue

Interventions: Device: Existing Biofeedback
Device: Biofeedback accompanied with virtual reality

First Posted Date: 2016-12-08

Last Posted Date: 2016-12-08

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 80

Registration Number: NCT02986555

Locations: 🇰🇷
Samsung Medical Center, Seoul, Irwon-dong, Gangnam-gu, Korea, Republic of

Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor and Amyloid Neuroimaging

Conditions: Major Depressive Disorder

First Posted Date: 2016-12-06

Last Posted Date: 2016-12-06

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 60

Registration Number: NCT02983838

Locations: 🇰🇷
Samsung Medical Center, Seoul, Irwon-dong, Gangnam-gu, Korea, Republic of

Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer

Phase 3

Conditions: Surgery: Axillary Dissection
Breastcancer

Interventions: Device: adhesive barrier

First Posted Date: 2016-11-18

Last Posted Date: 2017-01-05

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 170

Registration Number: NCT02967146

Locations: 🇰🇷
Samsung Medical Center, Seoul City, Korea, Republic of

BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian Cancer

Completed

Conditions: To Investigate the Prevalence of BRCA 1/2 Mutation Among Ovarian Cancer

Interventions: Genetic: Ion AmpliSeq BRCA 1/2 Panel (Life Technologies, Carlsbad, CA, USA) ,Ion PGM platform

First Posted Date: 2016-11-15

Last Posted Date: 2016-11-15

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 298

Registration Number: NCT02963688

Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer

Conditions: Pancreatic Cancer

First Posted Date: 2016-10-17

Last Posted Date: 2019-04-17

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 100

Registration Number: NCT02934984

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy